JADPRO Live 2017 Activities
Updates in Heme Malignancy Side Effects
Myeloproliferative Neoplasms Updates
Knowledge Center: Oral Oncolytics
Narratives: HER2-Positive Breast Cancer
An Advanced Practitioner’s Guide to Cell Signaling Pathways in NSCLC
What are the mechanisms of action of targeted treatments and immunotherapies?
Melinda Oliver: How do you identify and manage adverse events?
Melinda Oliver: How do you interpret a patient’s therapeutic response to treatment?
Frank E. Mott: What are the genetic variants in NSCLC, and how are they used to select treatment?
Frank E. Mott: What is the current thinking on diagnosis and treatment of patients with squamous cell NSCLC?
Copyright © 2010-2018 Harborside Press, LLC All rights reserved.
Bot trap - Don't go here
to learn more.